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Abstract
Background: Of the 14.3 million Mexicans who smoke, only a minority take advantage of evidence-based approaches to
smoking cessation. Mobile health interventions have the potential to increase the reach of effective cessation interventions in
Mexico.
Objective: This study aimed to assess the feasibility and acceptability of an innovative, personalized, and interactive smoking
cessation mobile intervention developed for Mexican smokers.
Methods: We recruited 40 Mexican smokers to participate in Vive sin Tabaco... ¡Decídete!, a smoking cessation program that
uses a tablet-based decision support software to drive a 12-week text messaging smoking cessation program and pharmacotherapy
support. Outcome measures included participant text messaging interactivity with the program, participant satisfaction, and
12-week verified abstinence using urinary cotinine testing or exhaled carbon monoxide.
Results: Average age of the participants was 36 years (SD 10.7), and they were primarily male (65%, 26/40) with at least an
undergraduate degree (62%, 25/40). Most participants (95%, 38/40) smoked daily and were interested in quitting in the next 7
days. As an indicator of participant interactivity, participants sent an average of 21 text messages during the 12-week intervention
(SD 17.62). Of the 843 messages that participants sent to the program, only 96 messages (11.3%, 96/843) used keywords. At 12
weeks, 40% (16/40) of participants were biochemically verified (87%, 35/40, follow-up rate). The majority of participants (85%,
30/35) reported being very satisfied or extremely satisfied with the program.
Conclusions: The Vive sin Tabaco... ¡Decídete! smoking cessation mobile intervention was accepted by participants, generated
high satisfaction and high text messaging interactivity, and resulted in a noteworthy cessation rate at the end of treatment. This
intervention is a promising strategy for smoking cessation in Mexico. Additional testing as a formal randomized clinical trial
appears warranted.
(JMIR Mhealth Uhealth 2019;7(4):e12482)  doi: 10.2196/12482
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Currently, 14.3 million Mexican adults (16.4%) smoke [1], and
it is expected that more than 4 million will die of tobacco-related
diseases in the next decade if smoking prevalence remains
unchecked [2]. The prevalence of smoking has remained
relatively consistent over the last decade [1,3], despite
implementation of taxes [4,5], smoke-free policies [6,7], health
warnings on cigarette packages [8-10], and advertising
restrictions [11], as recommended by the World Health
Organization’s Framework Convention on Tobacco Control
[12]. The potential for reducing the projected morbidity and
mortality associated with smoking depends greatly on reaching
smokers and delivering cost-effective cessation interventions.
Currently, 8 in 10 Mexican smokers are interested in quitting
smoking [1]. However, less than 10% of Mexican smokers take
advantage of the evidence-based approaches to smoking
cessation (pharmacotherapy and counseling) [1] that are offered
by the public health care system [13-15]. Although health care
providers in Mexico are encouraged to address smoking with
their patients in every visit [16,17], most health care providers
fail to initiate cessation treatment [18]. Overcoming the burden
of tobacco use in Mexico demands affordable, accessible, and
effective solutions.
Mexicans are more likely to be nondaily and light smokers (<10
cigarettes per day [CPD]) [1,19]. The 2015 Global Adult
Tobacco Survey in Mexico found that 53.7% of current smokers
are nondaily smokers and, among daily smokers, the average
number of CPD was 7.7 [1]. Light smokers believe their lower
level of smoking reduces or eliminates their health risk despite
evidence to the contrary [20]. Light smoking significantly
increases the risk for cancer, all-cause mortality, and adverse
cardiovascular outcomes [21]. It is important to identify
innovative smoking cessation strategies tailored to the needs of
Mexican smokers.
Developments in the sophistication of mobile technologies allow
for flexible delivery of text messages, with algorithms used to
tailor content to individual motivational and behavioral needs
for smoking cessation [22-26]. A number of studies have
examined the effectiveness of text messaging interventions to
promote and support smoking cessation [27-29]. A Cochrane
meta-analysis of these studies indicates that text messaging
interventions increase the likelihood of staying quit by
approximately 1.7 times (9.3% quit rate with text messages vs
5.6% quit rate with no program) [27]. All the studies included
in the meta-analysis were conducted in high-income countries
with limited generalizability to low- and middle-income
countries. Reflecting the global trend in the uptake of cell
phones, Mexico is the eleventh largest mobile market in the
world, with 107.8 million active cell phones [30] for its 123
million inhabitants [31]. The very high rate of cell phone
ownership, the low use of smoking cessation treatments, and
the evidence that text messaging can enhance a smoking
cessation intervention provide a unique opportunity to assess a
smoking cessation mobile intervention in Mexico. Considering
this premise, the US National Cancer Institutes’ text messaging
program [32] was adapted for Mexican smokers interested in
quitting using focus groups and interviews [33]; however, no
formal evaluation of that effort has been done.
Objective
This pilot study aimed to assess the feasibility and acceptability
of Vive sin Tabaco... ¡Decídete!, an innovative smoking
cessation mobile intervention for Mexican smokers. This mobile
innovation is achieved by connecting a Web-based
decision-making tool used to develop a personalized quit plan
with the delivery of tailored text messages over 12 weeks.
Results from this study will inform future implementation and
dissemination studies to achieve significant reductions in
tobacco-related morbidity and mortality in Mexico and provide




This study was conducted between March and August 2017 at
the Medical Center of the Autonomous University of the State
of Morelos, located in Cuernavaca, Morelos, Mexico. This urban
primary health care clinic serves an average of 100 individuals
on a daily basis. None of the services provided by the clinic
address smoking cessation.
Participants
Participants were recruited through printed posters and
multimedia venues including ads through the National Institute
of Public Health’s website and Facebook and local radio
announcements. Potential participants emailed or called the
study personnel to learn more about the study. Eligibility
assessment was conducted over the phone. Eligible participants
were of Mexican origin, aged 18 years or older, had smoked
for at least 6 months, smoked at least 3 days per week, were
interested in quitting within the next 30 days, had a cell phone
with text messaging capacity, and were willing to complete
baseline and 12-week follow-up surveys. Participants were
excluded from the study if they were planning to move within
the next 6 months, consumed other forms of tobacco (including
electronic cigarettes) or illicit drugs in Mexico (eg, cannabis
and cocaine), or had another household member enrolled in the
study. All subjects gave informed consent before participation
in the study. Participants received 300 Mexican pesos
(approximately US $17) at baseline and follow-up as an
incentive for their time and transportation. The Human Subjects
Committee of the National Institute of Public Health approved
the study procedures.
Intervention
Vive sin Tabaco... ¡Decídete! is a smoking cessation mobile
intervention that encompasses 3 integrated components: (1) a
tablet-based software that collects personal smoking-related
information to support the development of an individualized
quit plan and guides the ensuing text messages program, (2) a
12-week individually tailored text messages program with
interactive capabilities, and (3) pharmacotherapy support when
applicable.
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Vive sin Tabaco... ¡Decídete! Tablet-Based Software
The tablet-based, decision support tool was designed to help
smokers create a personalized smoking cessation plan and to
collect data that tailored the text messages delivered over the
ensuing 12 weeks [34]. This tool was adapted from 2 smoking
cessation Web-based, informed decision-making tools for
Latinos in the United States [35] and Mexico [36,37]. This
tablet-based tool consisted of interactive features that lead
smokers through various steps in the quitting process. The
program included testimonies from ex-smokers and features
short video clips (0:21-2:03 min) and narrated graphics on the
benefits of quitting while also describing how cessation
pharmacotherapy (nicotine replacement therapy [NRT]) can
support abstinence. The program also collected basic
information about the participants’ smoking history, including
the number of days they smoke each week and the number of
cigarettes smoked per day. At the end of the 10- to 15-min
session, participants were prompted to request pharmacotherapy
if interested and clinically recommended and to select a quit
date within a 30-day timeframe. Upon completion of the
tablet-based software, participants were provided with a 1-page
summary of their personalized cessation plan (eg, the selected
quit date and pharmacotherapy with the recommended dose and
regimen). Next, participants automatically began receiving the
text message portion of the intervention.
Vive sin Tabaco... ¡Decídete! Text Messaging
We developed a library of 304 text messages in Spanish to
support a 12-week cessation program [38] based on the social
cognitive theory [39]. Text messages were informed by literature
reviews on educational facts and strategies for smoking
cessation, feedback from national tobacco control experts, and
results from focus groups with Mexican smokers and
ex-smokers. The text message intervention allowed 3 levels of
interactivity: (1) prescheduled standard messages, (2)
keyword-triggered standard messages, and (3)
counselor-personalized responses.
Prescheduled Standard Messages
The main goal of the prescheduled standard messages was to
provide counseling through educational (eg, health risks of
smoking, immediate and long-term benefits of quitting smoking,
and how to correctly use the pharmacotherapy), motivational
(eg, intrinsic and extrinsic motivation), and behavioral (eg,
reminders to use strategies to cope with triggers, self-control
through goals, self-monitoring, and prompts to order NRT)
messages to facilitate quitting and supporting abstinence.
Messages were automatically tailored to the participant’s
name(s), gender, pharmacotherapy indication, and the selected
quit date. Text messages were organized along a 12-week
timeline designed to support a personalized quit plan: (1) prequit
(29 days), (2) quit day (1 day), (3) maintenance (28 days), and
(4) relapse prevention (8 weeks). The content and number of
messages varied as the intervention progressed (see Table 1).
Keyword-Triggered Standard Messages
These messages consisted of automated immediate responses
sent to participants who texted 1 of the following keywords:
Antojo (Spanish for “Crave”), Estrés (Spanish for “Stress”),
Recaída (Spanish for “Relapse”), Familia (Spanish for
“Family”), Tristeza (Spanish for “Sadness”), and Consejo
(Spanish for “Advice”). In addition, throughout the 12-week
program, participants received 7 response-triggered (YES or
NO) text messages to assess their smoking status (eg, ¿Sigues
sin fumar? Responde SÍ o NO y te ayudaremos. ¡Seguimos
contigo! [Spanish for “Are you still smoke-free? Reply YES or
NO and we will help you. We are here with you!”]). If
participants indicated that they were smoking, these automated
messages encouraged them to set a new quit date. Following
the Mexican Federal Telecommunications Institute regulations,
participants could withdraw from the text message program at
any moment by sending the keyword Alto (Spanish for “Stop”)
[40].
Counselor-Personalized Responses
Taking advantage of the text message platform’s capability to
recognize free texting (nonkeyword) from participants, Vive sin
Tabaco... ¡Decídete! encouraged participants to text any
feelings, concerns, and/or questions to the program (eg, Puedes
escribirnos en todo momento. Te apreciamos y nuestro
compromiso es ayudarte. ¡Recuérdalo! [Spanish for “You can
text us at any time. We appreciate you and we are committed
to help you. Remember it!”]). A trained smoking cessation
counselor answered these messages following standardized
protocols (eg, motivational interview and pharmacotherapy
delivery, use, adherence, and side effects). The counselor was
trained on the Basic Skills for Working with Smokers course
by The University of Massachusetts Medical School [41]. The
counselor monitored and triaged queries daily, responding within
24 hours of receipt of text messages sent by participants.
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Table 1. Types of messages, stages, duration, number, and examples of text messages.
ExamplesNumberDurationStageType of message
[Nombre], crea un grupo que te apoye en este proceso, pueden
ser tus familiares y amistades más cercanas. Diles que a partir
2 to 3 messages a day29 daysPrequitPrescheduled standard mes-
sages
de [Fecha para dejar de fumar] dejarás de fumar. ¡Cuenta con
ellos(as), cuenta con nosotros!; [Name], create a group that will
support you through this process, it can be your family and close
friends. Tell them that from [Quit date] you will quit smoking.
Count on them, count on us!;
¡BUENAS NOTICIAS! Dejando de fumar cuidas el medio am-
biente. ¿Cómo? Cada año, la industria tabacalera es respons-
able de la tala de 600 millones de árboles; GOOD NEWS! By
quitting smoking, you are taking care of the environment. How?
Each year, the tobacco industry is responsible for cutting down
600 million trees.;
[Nombre], al dejar el cigarro te convertirás en un ejemplo para
otros, ¡muchos querrán lograrlo como tú!; [Name], when you
quit smoking, you become a role model to others, many will
want to stop smoking like you!;
La vida está llena de retos, dejar de fumar es uno más que vas
a superar. Piensa en lo bien que te sentirás cuando lo hayas
logrado; Life is full of challenges, quitting smoking is one more
challenge you will overcome. Think about how good you will
feel once you achieve it!
[Nombre], ¡FELICIDADES! Ha llegado el día. Hoy comienzas
una nueva vida. Recuerda por qué estás dejando de fumar;
4 messages1 dayQuit dayPrescheduled standard mes-
sages
[Name], CONGRATULATIONS! The day has arrived. Today
you start a new life. Remember why you are quitting smoking;
[Nombre], ¿cómo te sientes? Sabemos que las primeras 24
horas son las más difíciles, ¡recuerda que cuentas con nosotros!
Escríbenos; [Name], how are you feeling? We know the first
24 hours are the most difficult, remember that you can count
on us! Text us
Dejar de fumar es una decisión que se toma todos los días.
Reafírmala cada mañana. ¡Lo estás logrando!; Quitting
3 to 4 messages a day28 daysMaintenancePrescheduled standard mes-
sages
smoking is a decision you make every day. Reaffirm it each
morning. You are doing it!;
[Nombre], ¿estás disfrutando esta nueva etapa de tu vida?
Cuéntanos lo que más te gusta de haber dejado de fumar;
[Name], are you enjoying this new stage in your life? Tell us
what you like the most about no longer smoking.;
¿Ya publicaste en Facebook que dejaste de fumar? ¡Te sorpren-
derá ver la respuesta positiva de todos!; Have you posted on
Facebook that you quit smoking? You will be surprised to see
the positive responses from everyone!;
¿Ya probaste tu platillo favorito ahora que dejaste el cigarro?
Redescubre su sabor, ¡disfrútalo!; Have you tried your favorite
dish now that you quit smoking? Rediscover its flavor. Enjoy
it!
Hoy puedes decir: “¡Soy [Nombre] y llevo 35 días sin fumar!
¡Sigo adelante!; Today you can say, ”I am [Name] and I have
gone 35 days without smoking! I can keep going!“;
¡Felicidades [Nombre]! Ahora que dejaste de fumar, es menos
probable que tus hijos(as) lo hagan. ¡Sigue cuidando tu futuro




y el de los tuyos!; Congratulations [Name]! Now that you
stopped smoking, it is less likely that your children will do it.
Keep taking care of your future and the future of your loved
ones!;
[Nombre], planea un bonito fin de semana con las personas
que más quieres. ¡6 semanas sin fumar es un gran motivo para
celebrar!; [Name], plan a nice weekend with the people you
love the most. 6 weeks without smoking is a great reason to
celebrate!
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Recaer no significa que has perdido la batalla, recaer nos da
la oportunidad de aprender y salir victoriosos. ¡Inténtalo una
vez más!; To relapse does not mean you have lost the battle; to
relapse gives you the opportunity to learn and become victori-
ous. Try it one more time!;
[Nombre], ¿qué te hace fumar? Cuéntanos. Juntos encon-
traremos nuevas soluciones para dejar el tabaco; [Name], what
makes you smoke? Tell us. We can find new solutions together
to quit tobacco
4 messages a day3 daysRelapsePrescheduled standard mes-
sages
Dejar de fumar vale la pena por ti y por tus seres queridos.
[Nombre], ¡te felicitamos por tu esfuerzo! ¡Sigue adelante!;
Quitting smoking is worth it for the sake of you and your loved
ones. [Name], we congratulate for your effort! Keep going!;
[Nombre], dejar de fumar también demuestra amor a tu familia.
Sigue así, ¡vas muy bien!; [Name], quitting smoking also shows





Deja lo que estás haciendo y camina por 5 minutos. Te dis-
traerás y el antojo desaparecerá; Drop what you are doing and
walk for 5 minutes. It will distract you and the cravings will go
away.;
[Nombre], piensa en lo lejos que has llegado. No vale la pena
volver a fumar, ¡sigue adelante!; [Name], think of how far you





Inhala profundo por 3 segundos, aguanta el aire por otros 3,
y exhala por 6 segundos. Mientras respiras hondo, imagina que
estás en un lugar bello y tranquilo. Repítelo, ¡esto te relajará!;
Inhale deeply for 3 seconds, hold your breath for another 3
seconds, and exhale for 6 seconds. While you breathe deeply,
imagine that you are in a beautiful and peaceful place. Repeat
it; this will relax you!;
[Nombre], escucha tu música favorita, te servirá para controlar
el estrés. ¡Será de mucha ayuda!; [Name], listen to your favorite





¡Mantente ocupado! Hay tantas cosas que puedes hacer sin
fumar: ir al cine, ir por un café, leer, bailar, ejercitarse; Keep
yourself busy! There are so many thing that you can do without
smoking: go to the movies, go for a coffee, read, dance, and
exercise;
[Nombre], caminar al menos 15 minutos al día es excelente
durante el proceso para dejar de fumar, ¡muévete!; [Name],






[Nombre], ¿sabías que el ejercicio mejora tu estado de ánimo?
El ejercicio te hará sentir bien física y mentalmente. Camina,
baila o ve al gimnasio. Te ayudará a conseguir tu objetivo;
[Name], did you know exercising improves your mood? Exer-
cising will make you feel better, both physically and mentally.
Walk, dance, or go to the gym. It will help you reach your goals;
[Nombre], la gente que nos rodea influye en nuestro estado de
ánimo. Trata de rodearte de personas positivas, que te hagan
sentir bien; [Name], people around us affect our mood. Try to






The choice of pharmacotherapy followed the practice guidelines
for treating smokers in Mexico [16,17]. Only daily smokers
who smoked 6 or more CPD were eligible to use nicotine
patches. Nicotine patches were contraindicated in participants
who (1) had a heart attack in the last 2 months, (2) had a stroke
in the last 6 months, (3) have been diagnosed with an arrhythmia
or tachycardia, (4) have uncontrolled hypertension, and (5) were
using warfarin. Nicotine patches were not offered to these
participants. Participants who smoked 10 or more CPD and had
no contraindications were offered to use 10 weeks of nicotine
patches: 21-mg nicotine patches to be used during the first 6
weeks, followed by 14-mg nicotine patches for 2 weeks, and
7-mg patches for the last 2 weeks. Participants who smoked
between 6 and 9 CPD and had no contraindications were offered
to use 8 weeks of nicotine patches: 14-mg nicotine patches to
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be used during the first 6 weeks, followed by 7-mg patches for
the last 2 weeks. The NRT was provided in 2 phases. At
baseline, each participant received a 4-week supply if they were
eligible and interested in using it. Beginning at the second week
of the intervention, participants received text message queries
to see if they were interested in receiving more NRT. If a
participant indicated such an interest, a 4- or 6-week supply was
shipped to their home. Participants were prompted to start using
their nicotine patches on their selected quit date.
Gateway Infrastructure
To implement the text messages system, we worked with Agile
Health Inc [42], a text messaging health company, which hosted
the software to interface with the Vive sin Tabaco... ¡Decídete!
tablet-based software [34]. We utilized Agile Health ’s platform
and application program interface to create a customized system
to support the smoking cessation program. The platform allowed
the counselor to monitor the text messages sent by the
participants and categorize the messages using keywords (which
triggered an automatic response) and counselor-required
messages. The platform allowed the counselor to interact with
participants while being able to see the text message history
and other participant information such as age, gender, and the
date they started the intervention. Text messages were delivered
through Auronix [43], a text message gateway in Mexico
identified through market research and technical testing. Auronix
’s service provider had the capacity to (1) engage bidirectional
real-time communication through a short code, (2) connect to
all carriers in Mexico, (3) receive participants’ text messages
containing special characters used in Spanish (ñ á é í ó ú ¡ ¿),
and (4) send a large number of text messages from Agile Health
’s platform.
Measures
The in-person baseline survey assessed sociodemographic
variables such as age, gender, education level, marital status,
and type of health insurance. Other variables collected were
physical nicotine dependence (the Fagerström Test for Nicotine
Dependence [44]—a 6-item test that evaluates the quantity of
cigarette consumption, the compulsion to use, and the
dependence), the number of cigarettes smoked per day, and the
number of previous quit attempts. We also assessed the
frequency of messages that participants sent to the program,
including the use of keywords, across each stage of the
intervention. At 12 weeks after enrollment, an in-person
follow-up survey was conducted by trained research staff and
biological samples were collected to verify cessation status.
Acceptability measures included satisfaction questions such as
“How satisfied are you with the smoking cessation text message
program?”
Outcomes
The primary outcome was cotinine-verified 7-day point
prevalence abstinence (no cigarettes in the past 7 days) at 12
weeks. This was biochemically verified using urinary cotinine
testing, with a cutoff of 200 ng/ml cotinine [45,46]. If the
participant was still using NRT, exhaled carbon monoxide, with
a cutoff of 6 ppm [45], was used to verify smoking abstinence.
The secondary outcomes were acceptability of the program and
text messaging interactivity.
Data Analysis
We calculated simple frequencies for categorical variables and
means and SDs for continuous variables. The primary analysis
on cessation was conducted using an intention-to-treat analysis,
in which participants lost to follow-up are considered smokers.
Results
Participant Recruitment and Characteristics
During a single week of recruitment, 122 smokers contacted
the study personnel via phone or email for information; among
them, 106 were contacted and assessed for eligibility by
telephone and 72 were identified as eligible for the study.
Overall, 41 smokers consented to participate and completed the
baseline assessment in person; 1 smoker was removed from the
study because of a carrier blockage that could not be solved,
resulting in 40 smokers enrolled in the study (Figure 1).
Participants’ age at baseline ranged from 20 to 59 years (mean
36.0, SD 10.7); 65% (26/40) of the participants were men, 50%
(20/40) were single, 62% (25/40) had college or postgraduate
education, and 80% (32/40) had health insurance coverage.
Most participants smoked daily (95%, 38/40) and were interested
in quitting in the next 7 days (95%, 38/40). Half of the
participants were light smokers (smoked 10 or less CPD) and,
according to the Fagerström test, 70% (28/40) of the participants
reported low levels of nicotine dependence (Table 2).
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Figure 1. Vive Sin Tabaco… ¡Decídete! intervention flow.
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Table 2. Baseline characteristics of participants (n=40).
StatisticsProfile characteristics
36.0 (10.7)Age, mean (SD)
Sex, n (%)
26 (65)Men
Education level, n (%)
3 (7)Less than high school graduate




Marital status, n (%)
16 (40)Married or cohabitating
20 (50)Single
4 (10)Divorced, separated, or widowed
Health coverage, n (%)
25 (62)Instituto Mexicano del Seguro Social (English: Mexican Social Security Institute)
7 (17)Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (English: Institute for Social Security and Services for
State Workers)
8 (20)None
Smoking pattern, n (%)
2 (5)Nondaily
20 (50)Daily, 1-9 CPDa
12 (30)Daily, 10-19 CPD
6 (15)Daily, 20 or more CPD




Quit attempt in the previous year , n (%)
26 (65)Yes
14 (35)No
aCPD: cigarettes per day.
Text Messaging Utilization
Participants received approximately 180 automated messages
during the 12 weeks; none of the participants texted the word
STOP to disenroll from the program. During the 12-week
intervention period, participants sent 843 text messages, an
average of 21 text messages per participant (SD 17.62). Of the
843 messages that participants sent to the program, only 96
(11.3%) used keywords. Participants varied in the frequency of
sending text messages: 3 (7%, 3/40) never interacted with the
program, 16 (40%, 16/40) had low interaction (1-9 messages),
17 (37%, 17/40) had medium interaction (10-49 messages), and
4 (10%, 4/40) had high interaction (>50 messages). Interaction
varied across the different stages of the program (Figure 2).
Interaction was very high at the beginning of the intervention
and on the quit date, decreasing progressively as the program
continued except for spikes on days 7, 14, 28, 42, 56, and 77
after the quit date. These spikes were because of smoking status
being assessed on those days via text message. Overall, 15 (37%,
15/40) participants notified the program that they had relapsed
and 7 (17%, 7/4-) set up a new quit date.
Pharmacotherapy Utilization
Three-quarters (75%, 30/40) of the participants were eligible
to use NRT, all of whom requested an initial supply of NRT.
Of these 30 participants who requested NRT at baseline, 18
(60%) requested a refill at 4 weeks (Figure 3).
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Figure 2. Text messages interaction by participants during the intervention. QD: quit day.
Figure 3. Utilization of nicotine replacement therapy (NRT) during the intervention. CPD: cigarettes per day.
Cessation, Retention, and Satisfaction
At 12 weeks, 16 participants (40%, 16/40) were biochemically
verified abstinent using intent-to-treat analysis (Table 3). The
follow up-rate at 12 weeks was 87.5%. Of the participants who
completed the follow-up assessment, most (85.7%) reported
being very satisfied or extremely satisfied with the program. In
addition, 17 participants (48.5%) reported not being able to send
text messages at some point of the intervention because of not
having enough credit on their cell phones.
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Table 3. The 3-month follow-up outcomes.
n (%)Outcome
Smoking Abstinence (n=40)a
18 (45)Self-reported 7-days smoking abstinence
15 (37)Biochemically verified abstinence urine cotinine (≤200 ng/ml)





aIntention-to-treat analysis was used.
Discussion
Principal Findings
To the best of our knowledge, Vive sin Tabaco... ¡Decídete! is
the first smoking cessation mobile intervention specifically
tailored to the needs of Mexican smokers. The program has a
unique 2-component platform that includes a tablet-based
program at baseline to collect information used to develop a
personalized quit plan and the delivery of the 12-week
messaging program. This system generated substantial interest
among smokers, as indicated by the rapid recruitment of our
sample within a single week. The program was well received
by the participants, most of whom engaged in high levels of
interactivity with the program (eg, bidirectional messaging) and
indicated high levels of participant satisfaction. The participants
also expressed a high level of interest in using NRT in
conjunction with the text messaging program. Although we did
not assess medication adherence, the vast majority of
participants used the text messaging program to request
additional NRT, suggesting that most participants completed
at least a 4-week course of therapy. The 40% rate of smoking
cessation seen at week 12 (end of treatment) appears promising
and is in line with end-of-treatment cessation rates seen in trials
of NRT that used substantial in-person counseling.
Implications for Future Research
A smoking cessation mobile intervention can only be effective
and sustainable if it is properly deployed in an environment that
reaches a large number of smokers in need of evidence-based
services. In Mexico, the most logical setting for the deployment
of Vive sin Tabaco... ¡Decídete! is within the universal health
care system, which is founded on a network of comprehensive
primary care clinics [47,48]. Primary health within Mexico’s
universal health care system follows established guidelines for
the identification and treatment of smokers [16,17]. However,
implementation of these guidelines has been limited because
of the lack of time during routine care, inadequate training of
personnel, and competing patient demands [18]. Vive sin
Tabaco... ¡Decídete! has the potential to overcome these barriers
as it was designed for easy integration into primary health
centers without disrupting clinical workflows.
The text messaging program appears to be a promising, low-cost
alternative to in-person or telephone counseling to prompt
smoking cessation, although additional strategies to eliminate
the costs incurred by participants generating text messages to
interact with the program may be needed. In this study,
participants preferred to send their own, self-composed text
messages rather than relying on keywords from the program
for a response. This suggests that reliance on keywords may be
insufficient for smoking cessation counseling via text messaging
in Mexico. Hence, there may be additional costs involved in
having trained personnel responding to participants’ text
messages, as occurred in this study. Participants’ text messages
content should be analyzed using qualitative methods to identify
common themes. These methods can guide the creation of a
categorized codebook that would be able to retrieve and send
responses automatically, thus reducing the need for trained
personnel responding to self-composed participants’ text
messages.
Limitations
This study had a number of limitations. This was a pilot study
and did not have a control group. Due to the small sample size,
the results are not generalizable to all Mexican smokers.
Follow-up was limited to a single assessment at week 12, when
the program ended. Analyses were limited to quantitative
assessments of participant interactions. Furthermore, the sample
was more highly educated and smoked more heavily than the
general population of smokers in Mexico; future research is
warranted to determine whether the effectiveness of this type
of intervention is generalizable to those who are from lower
socioeconomic status groups. Contrary to the US clinical
guidelines [49], NRT is contraindicated in Mexico for those
who smoke less than 6 cigarettes a day [17], which is a group
that represents about 75% of smokers in Mexico [1]. It is
possible that the cessation rate in this study could have been
higher if light smokers had access to NRT as determined in the
US clinical guidelines [49]. Despite these limitations, the study
suggests that Vive sin Tabaco... ¡Decídete! is highly acceptable
and holds promise for further testing, including a
cost-effectiveness analysis.
Conclusions
The Vive sin Tabaco... ¡Decídete! smoking cessation mobile
intervention was well accepted by participants, generated high
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satisfaction and frequent 2-way interactivity, and resulted in
noteworthy cessation rates at the end of treatment. The program
appears to offer a promising strategy for smoking cessation in
Mexico, particularly in the context of primary care clinics that
could deploy the Vive sin Tabaco... ¡Decídete! tablet to assist
participant enrollment. Additional testing in a formal
randomized clinical trial is needed before widespread
dissemination of Vive sin Tabaco... ¡Decídete!
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